Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2006

01-06-2006 | Editorial

A Surgical Indication in Incurable Breast Cancer

Author: William C. Dooley, MD

Published in: Annals of Surgical Oncology | Issue 6/2006

Login to get access

Excerpt

A recent review of the National Cancer Data Base suggested that there might be a survival benefit to resection of the primary breast cancer in patients with established metastatic disease—i.e., stage IV. Removal of a primary lesion in breast cancer rarely leads to spontaneous response or remission, as it might in renal cell carcinoma. We all remember the few women who seem to have metastatic disease blossom immediately after primary excision in breast cancer. How could it be that excision of the primary cancer will improve survival? Babiera and the M. D. Anderson group1 have performed a detailed review of this issue over the last several years at their institution. Although this is not a prospective randomized trial, it offers some insight into potential explanations for this apparent paradox of a survival benefit from incomplete tumor removal. …
Literature
1.
go back to reference Babiera GV, Rao R, Feng L, et al. Impact of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol (in press) Babiera GV, Rao R, Feng L, et al. Impact of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol (in press)
2.
go back to reference Schimke RT, Kung A, Sherwood SS, Sheridan J, Sharma R. Life, death, and genomic change in perturbed cell cycles. Philos Trans R Soc Lond B Biol Sci 1994; 345:311–7.PubMed Schimke RT, Kung A, Sherwood SS, Sheridan J, Sharma R. Life, death, and genomic change in perturbed cell cycles. Philos Trans R Soc Lond B Biol Sci 1994; 345:311–7.PubMed
3.
go back to reference Sherwood SW, Assaraf YG, Molina A, Schimke RT. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Cancer Res 1990; 50:4946–50PubMed Sherwood SW, Assaraf YG, Molina A, Schimke RT. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin. Cancer Res 1990; 50:4946–50PubMed
4.
go back to reference DeWald MG, et al. Heterogeneity in the mitotic checkpoint control of BALB/3T3 cells and a correlation with gene amplification propensity. Cancer Res 1994; 54:5064–70PubMed DeWald MG, et al. Heterogeneity in the mitotic checkpoint control of BALB/3T3 cells and a correlation with gene amplification propensity. Cancer Res 1994; 54:5064–70PubMed
Metadata
Title
A Surgical Indication in Incurable Breast Cancer
Author
William C. Dooley, MD
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2006.09.910

Other articles of this Issue 6/2006

Annals of Surgical Oncology 6/2006 Go to the issue